Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Kanan, W.
- Evaluation of CRP in Patients with Asthma
Abstract Views :481 |
PDF Views:0
Authors
Affiliations
1 Department of Physiology, JIPMER, Puducherry, IN
2 Department of Health Services, Manipur, IN
3 Department of Health Services, Meghalaya, IN
4 Regional Institute of Medical Sciences, Imphal, Manipur, IN
1 Department of Physiology, JIPMER, Puducherry, IN
2 Department of Health Services, Manipur, IN
3 Department of Health Services, Meghalaya, IN
4 Regional Institute of Medical Sciences, Imphal, Manipur, IN
Source
International Journal of Physiology, Vol 8, No 1 (2020), Pagination: 37-42Abstract
Patients with asthma have an ongoing inflammation, which can be assessed by measuring serum C- reactive protein.
Objective: To explore whether CRP could be used as a predictor of disease outcome in asthma. Methods: A Cross-sectional study was conducted among 50 asthma patients attending Respiratory Medicine outpatient services in Regional Institute of Medical Sciences (RIMS), Imphal from January 2015 to September 2016. Patients aged 18-67 were included in the study after obtaining Ethical approval from the Research Ethics Board, RIMS, Imphal. Computerized Spirometer Helios 401 was the instrument used to measure lung volumes and capacities. BeneSpheraTM CRP Latex Slide test kit was used to estimate serum C-reactive protein.
Results and Observation: The present study was conducted on fifty asthma patients in which serum CRP level showed association with severity of asthma ( p=0.001) but serum CRP level with spirometric parameters showed significant negative correlation; FVC (r=-0.711, p<0.001), FEV1 (r=-0.665, p<0.001), FEV1/FVC (r=-0.429, p=0.002), FEF25-75% (r=-0.535, p<0.001), and PEFR (r=-0.515, p<0.001).
Conclusion: In our study we found association between serum CRP level and asthma and plasma CRP may be used as a marker of prognosis in patients with asthma.
Keywords
C- Reactive Protein, Asthma.
References
- Asher MI, Montefort S, Björkstén B, Lai CK, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergy rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006;368(9537):733-43.
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2006). Available at: http://www.goldcopd.org. Accessed September 19, 2016.
- Bellamy D. Spirometry in practice: a practical guide to using spirometry in primary care. 2nd ed. London: BTS COPD Consortium; 2005.
- Block JL. Evaluation of cardiac injury and function. In: McPherson RA, Pincus MR, editors. Henry`s Clinical Diagnosis and Management by Laboratory Methods. 21st ed. New Delhi: Elsevier; 2009. p. 224-5.
- Sonnenwirth AC. Serological tests in infectious disease-II. In: Sonnenwirth, Jarett L, editors. Gradwohl`s Clinical Laboratory Methods and Diagonosis. 8th ed. New Delhi: B.I. Publications Ltd; 1990. p. 2328-31.
- Koshak EA. Classification of asthma according to revised 2006 GINA: Evolution from severity to control. Ann Thorac Med 2007;2(2):45-6.
- Kony S, Zureik M, Driss F, Neukirch C, Leynaert B, Neukirch F. Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study. Thorax 2004;59:892–896.
- Olafsdottir IS, Gislason T, Thjodleifsson B, et al. C reactive protein levels are increased in nonallergic but not allergic asthma: a multicentre epidemiological study. Thorax 2005;60:451–454.
- Sävykoski T, Harju T, Paldanius M, et al. Chlamydia pneumoniae infection and inflammation in adults with asthma. Respiration 2004;71:120–125.
- 15. Shimoda T, Obase Y, Kishikawa R, Iwanaga T. Serum high-sensitivity C-reactive protein can be an airway inflammation predictor in bronchial asthma. Allergy Asthma Proc. 2015;36:e23–8.
- M. Takemura, H. Matsumoto, A. Niimi, T. Ueda, H. Matsuoka, M. Yamaguchi, et al. High sensitivity C-reactive protein in asthma. Eur Respire J 2006; 27: 908-912.
- Relationship between Smoking and Obstructive Airways Disease
Abstract Views :459 |
PDF Views:0
Authors
Affiliations
1 Department of Physiology, JIPMER, Puducherry, IN
2 Department of Health Services, Manipur
3 DR TB Center, JNIMS Hospital, Imphal, Manipur, IN
4 Regional Institute of Medical Sciences, Imphal, Manipur, IN
1 Department of Physiology, JIPMER, Puducherry, IN
2 Department of Health Services, Manipur
3 DR TB Center, JNIMS Hospital, Imphal, Manipur, IN
4 Regional Institute of Medical Sciences, Imphal, Manipur, IN
Source
International Journal of Physiology, Vol 8, No 1 (2020), Pagination: 43-48Abstract
Obstructive airways disease is an important cause of mortality and morbidity around the world and smoking has a significant role in the development and progression of the disease. Objective: To analyse the relationship between smoking and obstructive airways disease. Method: A cross-sectional study was conducted among 100 patients with obstructive airways disease attending Respiratory Medicine outpatient services in Regional Institute of Medical Sciences (RIMS), Imphal from January 2015 to September 2016. Patients aged 18-67 were included in the study after obtaining Ethical approval from the Research Ethics Board, RIMS, Imphal. Computerized Spirometer Helios 401 was the instrument used to measure lung volumes and capacities. Results and observation: The present study was conducted on 100 patients with obstructive airways disease. The lung function test values of OAD patients showed that FVC, FEV1, and FEV1/FVC values were within normal limits. But FEF25-75%, and PEFR were lower suggesting that smaller airways were affected in obstructive airway disease. In our study we found that OAD was strongly associated with smoking status(p<0.001), smoking pack-years(p=0.000), and smoking duration(p<0.001). Conclusion: From the study results we conclude that that Obstructive airway disease was strongly associated with smoking. Smoking cessation is the best and most effective solution to this problem. Other measures such as screening with spirometric tests in high risk individuals especially the smokers in age group of 40-55 should be considered to reduce the mortality and morbidity due to Obstructive airway disease.Keywords
Obstructive Airways Disease (OAD), Smoking, Spirometric Test.References
- Weinberger SE, Rosen IM. Disturbances of respiratory function. In: Loscalzo J, editor. Harrison`s Pulmonary and Critical Care Medicine. New Delhi: McGraw-Hill; 2010. p. 25-35.
- Asher MI, Montefort S, Björkstén B, Lai CK, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergy rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006;368(9537):733-43.
- Celli BR, MacNee W, Agusti AA, Anzueto A, Berg B, Buist AS, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-46.
- Bellamy D. Spirometry in practice: a practical guide to using spirometry in primary care. 2nd ed. London: BTS COPD Consortium; 2005.
- Koshak EA. Classification of asthma according to revised 2006 GINA: Evolution from severity to control. Ann Thorac Med 2007;2(2):45-6.
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2006). Available at: http://www.goldcopd.org. Accessed September 19, 2016.
- Razi E, Ehteram H, Akbari H, Chavoshi V, Razi A. Evaluation of high-sensitivity C reactive protein in acute asthma. Tanaffos 2012;11(1):32-7.
- Halvani A, Tahghighi F, Nadooshan HH. Evaluation of correlation between airway and serum inflammatory markers in asthmatic patients. Lung India 2012;29(2):143-6.
- Perez-Padilla R, Fernandez R, Lopez Varela MV, Montes de Oca M,Muin ̃o A, Ta ́lamo C, et al. Airflow obstruction in never smokers in five Latin American cities: the PLATINO study. Arch Med Res2012;43(2):159-165
- Lo ́pez Varela MV, Montes de Oca M, Halbert R, Muin ̃o A, Ta ́lamoC, Pe ́rez-Padilla R, et al. Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study. Arch Bronconeumol 2013;49(11):468-474.
- Lopez Varela MV, Montes de Oca M, Halbert RJ, Muin ̃o A, Perez-Padilla R, Ta ́lamo C, et al. Gender related difference in COPD in five Latin American cities: The PLATINO study. Eur Respir J 2010;36(5):1034-1041.
- Llorde ́s M, Jae ́n A, Almagro P, Heredia JL, Morera J, Soriano JB, Miravitlles M. Prevalence, risk factors and diagnostic accuracy of COPD among smokers in primary care. COPD 2015;12(4):404-412.
- Jindal SK, Aggarwal AN, Gupta D, Agarwal R, Kumar R, Kaur T, Chaudhry K, Shah B. Indian study on epidemiology of asthma, respiratory symptoms and chronic bronchitis in adults (INSEARCH). Int J Tuberc Lung Dis 2012; 16:1270-77.
- Jindal SK, Aggarwal AN, Gupta D, Agarwal R, Kumar R, Kaur T, Chaudhry K, Shah B. Indian study on epidemiology of asthma, respiratory symptoms and chronic bronchitis in adults (INSEARCH). Int J Tuberc Lung Dis 2012; 16:1270-77.
- Agrawal S. Effect of indoor air pollution from biomass and solid fuel combustion on prevalence of self-reported asthma among adult men and women in India: findings from a nationwide large-scale cross-sectional survey. J Asthma 2012; 49:355-65